Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.30 | N/A |
PEG Ratio (TTM) | 0.01 | N/A |
P/S Ratio (TTM) | 0.67 | N/A |
P/B Ratio (TTM) | 0.69 | N/A |
P/FCF Ratio (TTM) | -0.58 | N/A |
Price to 5YR AVG Earnings Ratio | -0.03 | N/A |
Price to 5YR AVG FCF Ratio | -0.43 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -119.31% | N/A |
ROE (TTM) | -171.34% | N/A |
Net Profit Margin (TTM) | -237.77% | N/A |
ROIC 5YR AVG | -193.67% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -210.51% | -37.47% | -9.71% |
Revenue | -8.19% | 89.61% | 34.78% |
Net Income | -13.60% | -44.82% | -25.49% |
Cash Flow | -14.55% | -116.88% | -61.39% |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.17 | N/A |
Quick Ratio (TTM) | 1.17 | N/A |
D/E Ratio (TTM) | 0.70 | N/A |
Interest Coverage (TTM) | -2.27 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.08 | N/A |
Shares Outstanding Growth 5YR AVG | 45.73% | N/A |